Current location - Trademark Inquiry Complete Network - Tian Tian Fund - How to write the progress and shortcomings of BGI nucleic acid testing
How to write the progress and shortcomings of BGI nucleic acid testing

1. The nucleic acid testing sampling points have insufficient joint efforts.

Although each sampling point has established a sample collection team, specimen collection and transportation team, logistics material support team, security working team, etc., the coordination and cooperation of each team is insufficient; the public security, civil affairs, transportation, publicity, ecological and environmental protection and other relevant departments play a role in front-line positions.

Unfortunately, the staff did not go to the site to give personal instructions. The order at the sampling site was relatively chaotic and disorderly, and the 1-meter line requirement was not implemented well.

2. The scheduling of sampling and sample submission for inspection is unreasonable.

The county headquarters cannot coordinate and dispatch sampling and testing forces. Sample dispatchers cannot clearly grasp the testing capabilities and testing progress of each testing agency. The sample delivery workflow is complex and there are insufficient transfer vehicles. The requirement of 2 hours for specimen transportation is not implemented. Samples at sampling points

The backlog is obvious. Some testing institutions have no samples to receive and test. Some testing institutions have samples that exceed their testing capabilities and cannot reasonably match sample delivery and testing.

3. There are deficiencies in material supply support capabilities.

The sampling points were not arranged in a list-based or ledger-based manner for material storage and scheduling, and there was insufficient follow-up support.

After staff changed jobs, there was a shortage of disposable supplies such as isolation gowns, protective masks, and masks, posing safety risks for personal protection.

The jurisdiction has insufficient preparations for transfer boxes and transfer vehicles, which affects the transfer effect.

4. Operational behaviors such as sampling and transportation are irregular.

The sampling operations of some sampling personnel did not meet the standard operation requirements. During the sampling process, they touched the skin and limbs of the sampled people, and the personal protective equipment was not worn in a standardized manner, which posed the risk of cross-infection.

After some sampling personnel complete the sampling action, hand hygiene and disinfection are simple and cannot meet the requirements of standardized disinfection, posing safety risks.

5. Medical waste is not collected and transferred in time.

Medical waste is discarded at some sampling points at will and is not stored in special packaging bags in a standardized manner. After sampling, medical waste cannot be collected and bandaged in a standardized manner, resulting in medical waste overflow.

There is obvious confusion in the management and removal of medical waste generated at night, and the random discarding of medical waste at sampling points is even more obvious.